Palatin Announces Initiation Of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial In Patients With Dry…
Top-Line Results Currently Expected Second Half Calendar 2022
Palatin Technologies, Inc. a specialized biopharmaceutical company developing…
Artificial Intelligence | News | Insights | AiThority